Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

ProShares Ultra Nasdaq Biotechnology

+ Add to Watchlist

BIB:US

154.2700 USD 1.7300 1.11%

As of 20:10:00 ET on 03/03/2015.

Snapshot for ProShares Ultra Nasdaq Biotechnology (BIB)

Open: 155.1600 High - Low: 155.9900 - 150.7721 Primary Exchange: NASDAQ GM
Volume: 530,104 52-Week Range: 60.8913 - 157.4200 Beta vs NBI: 1.6898

ETF Chart for BIB

No chart data available.
  • BIB:US 154.2700
  • 1D
  • 1M
  • 1Y
156.0000
Interactive BIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIB

ProShares Ultra Nasdaq Biotechnology is an an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to twice (200%) the return of the Nasdaq Biotechnology Index.

Inception Date: 2010-04-08 Telephone: 1-240-497-6400
Managers: HOWARD S RUBIN / TODD BRUCE JOHNSON
Web Site: www.proshares.com

Fundamentals for BIB

NAV (on 2015-03-03) 154.2800
Assets (M) (on 2015-03-03) 671.0987
Shares out (M) 4.35
Market Cap (M) 671.07
% Premium -0.01
Average 52-Week % Premium 0.0110
Fund Leveraged Y
Fund Leverage Percent 200.0000 %

Dividends for BIB

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2010-09-21) 0.0220
Dividend Yield (ttm) -%

Performance for BIB

1-Month +12.55% 1-Year +53.37%
3-Month +17.99% 3-Year +89.36%
Year To Date +22.92% 5-Year -
Expense Ratio 0.95

Top Fund Holdings for BIB

Filing Date: 09/30/2014
Name Position Value % of Total
Amgen Inc 135,104 18,976,708 8.286%
Celgene Corp 198,177 18,783,216 8.201%
Gilead Sciences Inc 175,040 18,633,008 8.136%
Biogen Idec Inc 54,894 18,159,484 7.929%
Regeneron Pharmaceuticals Inc 46,708 16,839,168 7.352%
Vertex Pharmaceuticals Inc 100,624 11,301,081 4.934%
Alexion Pharmaceuticals Inc 55,617 9,222,411 4.027%
Mylan NV 192,724 8,767,015 3.828%
Illumina Inc 52,494 8,604,816 3.757%
BioMarin Pharmaceutical Inc 75,800 5,469,728 2.388%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil